- Record: found
- Abstract: found
- Article: not found
Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Wei Ren Chen
1 ,
Shun Ying Hu
1 ,
Yun Dai Chen
2 ,
Ying Zhang
1 ,
Geng Qian
1 ,
Jing Wang
1 ,
Jun Jie Yang
1 ,
Zhi Feng Wang
1 ,
Feng Tian
1 ,
Qing Xiu Ning
1
Nov 2015
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Several studies have shown that exenatide protects against ischemia-reperfusion injury and improves cardiac function in patients with acute ST-segment elevation myocardial infarction (STEMI). The effects of liraglutide, a glucagon-like peptide-1 analogue, on STEMI patients remain unclear. We planned to evaluate the effects of liraglutide on left ventricular function after primary percutaneous coronary intervention for STEMI.